Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial

Jassem, Jacek; Pienkowski, Tadeusz; Pluzanska, Anna; Jelic, Svetislav S; Gorbunova, Vera; Berzins, Juris; Nagykalnai, Thomas; Biganzoli, Laura; Aloe, Alessandra; Astier, Ludovic; Munier, Stephane

Rezultati

eNauka > Rezultati > Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial

Naziv:	Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial
Autori:	Jassem, Jacek; Pienkowski, Tadeusz; Pluzanska, Anna; Jelic, Svetislav S; Gorbunova, Vera; Berzins, Juris; Nagykalnai, Thomas; Biganzoli, Laura; Aloe, Alessandra; Astier, Ludovic; Munier, Stephane;
Godina:	2009
Publikacija:	ONKOLOGIE
ISSN:	0378-584X Onkologie Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 32 br. 8 str. 1-1
DOI:	10.1159/000226210
WoS-ID:	000269574600003
Scopus-ID:	2-s2.0-70249129810
URI:	https://enauka.gov.rs/handle/123456789/813951
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	23M23 - Rad u međ. časopisu

15
SCOPUS^TM

8
OpenCitations

15
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.